Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Marathon Petroleum Corp (MPC) Price & Performance

Adaptive Biotechnologies CorpTrade
Marathon Petroleum CorpTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Marathon Petroleum Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Marathon Petroleum Corp trades at $336.13 (market cap $94.48B). The key difference: Marathon Petroleum Corp is far larger — about 23.4× Adaptive Biotechnologies Corp's market cap, and Marathon Petroleum Corp pays a 1.19% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTMPC
Market Cap
$4.04B$94.48B
Sector
HealthEnergy
52-Week High
$25.45$336.42
52-Week Low
$12.30$159.11
Enterprise Value
$4.10B$121.00B
Dividend Yield
1.19%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Marathon Petroleum Corp

Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.

Read more on MPC